HCA Healthcare Inc (NYSE: HCA)’s stock price has plunge by -1.67relation to previous closing price of 381.81. Nevertheless, the company has seen a -2.62% plunge in its stock price over the last five trading sessions. businesswire.com reported 2025-05-21 that NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced a $5 million gift to the Thomas F. Frist, Jr. College of Medicine at Belmont University to support the Belmont Collaborative for Health Systems Innovation. Half of the gift will create the HCA Healthcare Health Systems Science Endowed Chair, and the other $2.5 million will be used for programmatic support in the Health Systems Science department. HCA Healthcare’s.
Is It Worth Investing in HCA Healthcare Inc (NYSE: HCA) Right Now?
HCA Healthcare Inc (NYSE: HCA) has a price-to-earnings ratio of 16.68x that is above its average ratio. Additionally, the 36-month beta value for HCA is 1.50. There are mixed opinions on the stock, with 13 analysts rating it as a “buy,” 2 rating it as “overweight,” 9 rating it as “hold,” and 1 rating it as “sell.”
The public float for HCA is 170.54M and currently, short sellers hold a 2.60% ratio of that float. The average trading volume of HCA on May 22, 2025 was 1.68M shares.
HCA’s Market Performance
HCA’s stock has seen a -2.62% decrease for the week, with a 11.74% rise in the past month and a 18.64% gain in the past quarter. The volatility ratio for the week is 2.14%, and the volatility levels for the past 30 days are at 2.96% for HCA Healthcare Inc The simple moving average for the past 20 days is 4.09% for HCA’s stock, with a 7.77% simple moving average for the past 200 days.
Analysts’ Opinion of HCA
Many brokerage firms have already submitted their reports for HCA stocks, with Robert W. Baird repeating the rating for HCA by listing it as a “Neutral.” The predicted price for HCA in the upcoming period, according to Robert W. Baird is $336 based on the research report published on April 15, 2025 of the current year 2025.
JP Morgan, on the other hand, stated in their research note that they expect to see HCA reach a price target of $380. The rating they have provided for HCA stocks is “Neutral” according to the report published on December 17th, 2024.
Wells Fargo gave a rating of “Underweight” to HCA, setting the target price at $320 in the report published on November 25th of the previous year.
HCA Trading at 8.85% from the 50-Day Moving Average
After a stumble in the market that brought HCA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.00% of loss for the given period.
Volatility was left at 2.96%, however, over the last 30 days, the volatility rate increased by 2.14%, as shares surge +10.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +20.49% upper at present.
During the last 5 trading sessions, HCA fell by -2.21%, which changed the moving average for the period of 200-days by +7.65% in comparison to the 20-day moving average, which settled at $360.75. In addition, HCA Healthcare Inc saw 25.08% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HCA starting from Foster Jon M, who sale 15,698 shares at the price of $369.32 back on May 13 ’25. After this action, Foster Jon M now owns 12,646 shares of HCA Healthcare Inc, valued at $5,797,661 using the latest closing price.
Foster Jon M, the Officer of HCA Healthcare Inc, proposed sale 15,698 shares at $369.32 during a trade that took place back on May 13 ’25, which means that Foster Jon M is holding shares at $5,797,660 based on the most recent closing price.
Stock Fundamentals for HCA
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.68 for the gross margin
The net margin for HCA Healthcare Inc stands at 0.08. The total capital return value is set at 0.23.
Based on HCA Healthcare Inc (HCA), the company’s capital structure generated 1.08 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at -13.2. The interest coverage ratio of the stock is 5.17.
Currently, EBITDA for the company is 13.9 billion with net debt to EBITDA at 3.23. When we switch over and look at the enterprise to sales, we see a ratio of 1.9. The receivables turnover for the company is 6.46for trailing twelve months and the total asset turnover is 1.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.19.
Conclusion
In conclusion, HCA Healthcare Inc (HCA) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
